Diversified End Market Growth
Sales to diversified end markets increased by 28% year-over-year in Q4 and constituted 56% of the overall company revenue in Q4 and 51% for the full year 2024.
Gross Margin Improvement
Adjusted gross margin for the full year 2024 improved by 243 basis points compared to 2023, and by 394 basis points in Q4 year-over-year.
Aerospace and Defense Revenue Growth
Full year 2024 sales in the aerospace and defense sector were up 37% compared to 2023, indicating strong performance in this segment.
Medical Market Success
The company's medical market sales grew by 3% year-over-year for the full year 2024, with several new customer acquisitions and product wins.
Strong Cash Flow Generation
The company generated $99 million in operating cash flow for the full year, up from $89 million in 2023, and maintained a strong balance sheet.